Med Interactions
Hey Grok, my doctor has added Sildenafil 20 mg 3 times a day to my meds. I take my Hydroxychloroquine sulfate 200 mg at lunch to keep my Omeprazole 20 mg from interfering with the Hydroxychloroquine. Is it ok to take the Sildenafil at lunch with my Hydroxychloroquine? Is there anything I should be concerned about adding Sildenafil to my daily meds?
I’m not a doctor, and this is not personalized medical advice. Always consult your prescribing physician (rheumatologist or cardiologist) and/or pharmacist before starting sildenafil or making any changes to your regimen. They have your full history, labs, echoes, and can review interactions in context—especially with your scleroderma, possible pulmonary hypertension (PH/PAH) evaluation, SVT history, and current meds including nitroglycerin ointment, diltiazem, flecainide, and hydroxychloroquine (HCQ). Use a pharmacist-led medication review or interaction checker for your exact list.
Timing Sildenafil at Lunch with HCQ
Based on available drug information, taking sildenafil 20 mg at lunch alongside your HCQ 200 mg appears acceptable from a timing/interaction standpoint with HCQ or omeprazole.
Sildenafil (Revatio dosing for PH) can generally be taken with or without food; a high-fat meal may delay absorption slightly, but this is usually not clinically significant for three-times-daily maintenance dosing. There are no major pharmacokinetic interactions flagged between sildenafil and HCQ or omeprazole in standard checkers. Omeprazole (a PPI) raises gastric pH, and one study noted potentially reduced bioavailability of standard sildenafil tablets with PPIs due to pH-dependent solubility, but this is not highlighted as a major clinical concern in human interaction databases, and your doctor prescribed the sildenafil knowing your omeprazole use.
Note on your current HCQ + omeprazole schedule: Some sources recommend separating HCQ from antacids or PPIs by at least 4 hours because they may reduce HCQ absorption (similar to chloroquine data), though one study found no significant difference in HCQ levels. Your doctor has you on the lunch timing specifically to manage any interference, so continue following their instructions unless they advise a change. Adding sildenafil at the same meal time shouldn’t create a new conflict.
Discuss the exact daily schedule (e.g., morning/lunch/evening spacing) with your prescriber or pharmacist for consistency with PAH dosing.
Key Concerns Adding Sildenafil to Your Meds
Sildenafil is a PDE5 inhibitor commonly used for pulmonary arterial hypertension (PAH) associated with systemic sclerosis/scleroderma. Studies show it can improve exercise capacity, hemodynamics, and functional class in SSc-PAH patients, and it may also help with Raynaud’s phenomenon or digital ulcers. Given your rising estimated RVSP (30 → 50-55 mmHg) with stable DLCO and exercise desaturation, this addition aligns with addressing possible vascular involvement/PH.
However, there are important potential interactions and risks with your regimen that require close medical oversight:
• Nitroglycerin 2% ointment (major/contraindicated interaction): This is the most critical concern. Sildenafil combined with any form of nitroglycerin (including topical ointment) can cause profound, dangerous hypotension, dizziness, fainting, cardiovascular collapse, or worse. Warnings apply even to topical use due to potential systemic absorption. In scleroderma/Raynaud’s contexts, both are sometimes used separately, but they are not recommended together. One patient forum note in scleroderma groups explicitly flags this as a serious issue doctors address by stopping the nitro ointment.
Action: Contact your doctor immediately to clarify how to handle your nitroglycerin ointment. Options might include discontinuing it (sildenafil itself can help Raynaud’s), using it only PRN with strict timing windows (generally avoid nitrates within ~24 hours of sildenafil), or switching therapies. Do not start sildenafil until this is resolved.
• Diltiazem (major interaction potential): Diltiazem inhibits CYP3A4, which can significantly increase sildenafil blood levels and effects. Both drugs are vasodilators, raising the risk of hypotension, dizziness, lightheadedness, fainting, or other side effects. Your doctor may need to adjust the sildenafil dose, monitor blood pressure more closely, or watch for symptoms of excessive sildenafil (e.g., visual changes, headache, chest pain, irregular heartbeat).
• Hydroxychloroquine (possible additive QT prolongation risk): Both HCQ and sildenafil can affect heart rhythm (QT interval). Combined with your flecainide history and SVT, there is a theoretical increased risk of arrhythmias. Standard checkers note this possibility; ECG monitoring or caution may be warranted, especially with your cardiac background.
• Other considerations:
• Flecainide: No direct major interaction found, but combined cardiac effects (arrhythmia history + vasodilation) warrant monitoring.
• Common sildenafil side effects: Headache, flushing, nasal congestion, dyspepsia/indigestion, and transient visual changes (e.g., blue tint). These are often mild but could overlap with your fatigue, nausea, or possible gastroparesis symptoms—report anything new.
• Rosuvastatin, aspirin, Cellcept (mycophenolate), Actemra (tocilizumab): No major interactions expected from available data.
• General: Start low and titrate/monitor as your doctor directs. Watch blood pressure at home if possible. Report chest pain, severe dizziness, fainting, vision/hearing changes, or prolonged erection immediately. With possible PH evaluation (e.g., right heart cath discussion), sildenafil fits therapeutically but needs coordinated cardiopulmonary monitoring.
Your doctor likely reviewed your full list before adding sildenafil, but the nitroglycerin + diltiazem combinations are significant enough that a pharmacist reconciliation or explicit plan is wise—especially with your complex autoimmune + cardiac picture and recent symptoms (weight loss, fatigue, possible GI involvement).
Next steps I recommend:
• Call your rheumatologist, cardiologist, or prescribing doctor today/tomorrow to confirm safety, any dose adjustments, nitro management, and monitoring (BP, symptoms, follow-up echo/labs/ECG).
• Have your pharmacist do a full interaction review with your current list.
• Ask about timing specifics for the three daily doses and any precautions with meals or omeprazole.
• Track symptoms and BP; bring questions to your next appointment.
If you share more details from your doctor (e.g., exact reason for sildenafil, any new instructions, or upcoming tests), I can help look up general supporting information. Take care—hope this addition helps with the PH concerns and overall symptoms while keeping everything safe. Please prioritize that conversation with your healthcare team.
Thank you so very much. I will contact my doctor tomorrow. I will stop my Nitro Bid until I talk with him. One more question, I was taking Nifedipine 30Mg SA Tab for a while and was switched to Diltiazem 180 mg. Would Nifedipine be less of an issue?
I’m not a doctor—this is general information only. Please discuss this directly with your prescribing physician and pharmacist before making any changes to your medications, including switching back to nifedipine or adjusting anything. They know your full cardiac history (SVT, flecainide, diltiazem for BP/arrhythmia control), scleroderma details, recent echo changes, and other factors.
Short Answer on Nifedipine vs. Diltiazem with Sildenafil
Yes, nifedipine would generally be less of an issue than diltiazem when combined with sildenafil, primarily due to a pharmacokinetic difference:
• Diltiazem (a non-dihydropyridine calcium channel blocker) is a moderate inhibitor of CYP3A4, the main enzyme that metabolizes sildenafil. This can significantly increase sildenafil blood levels and effects, amplifying risks like hypotension (low blood pressure), dizziness, flushing, headache, or other side effects. There is both a pharmacokinetic (higher sildenafil exposure) and pharmacodynamic (additive vasodilation) interaction.
• Nifedipine (a dihydropyridine CCB) does not significantly inhibit CYP3A4, so it doesn’t raise sildenafil concentrations in the same way. The main interaction is pharmacodynamic—additive blood pressure-lowering effects from both being vasodilators—which can still cause hypotension symptoms (dizziness, lightheadedness, fainting, etc.), especially when starting or dose-adjusting. However, this is typically classified as a moderate interaction without the extra boost in sildenafil levels.
In practice, both CCBs are sometimes used alongside sildenafil in pulmonary hypertension (PH/PAH) or scleroderma management (e.g., for Raynaud’s), but diltiazem requires closer monitoring or possible sildenafil dose adjustment due to the CYP3A4 effect. Your doctor switched you to diltiazem previously for a reason (likely better arrhythmia/BP control in your case), so any reversion would need their input.
Other Reminders
• Nitroglycerin ointment: Great that you’re pausing it until you speak with your doctor— that’s the highest-risk combination with sildenafil (contraindicated due to risk of severe/profound hypotension).
• Overall monitoring: With either CCB + sildenafil, watch BP closely (home monitoring if possible), especially with your history. Report symptoms like dizziness, chest pain, irregular heartbeat, or worsening fatigue promptly.
• Scleroderma/PH context: Sildenafil is often added for possible PAH in systemic sclerosis, and CCBs like nifedipine are commonly used for Raynaud’s. Your team will balance the best option for your vascular, cardiac, and pulmonary needs.
Contact your doctor as planned—they may want to review your full regimen, consider alternatives, or order monitoring (e.g., BP logs, follow-up echo, or labs). If you have more details from the conversation or specific concerns, feel free to share (general info only). Take care, and I hope this helps manage things smoothly!